Navigation Links
Why Cancer Symptoms May Elude M.D.
Date:2/24/2012

FRIDAY, Feb. 24 (HealthDay News) -- Diagnosing cancer is more difficult in certain groups of patients, according to a British study.

Researchers analyzed data gathered from more than 41,000 patients with 24 types of cancer who were treated in 158 hospitals across England. They found that 77 percent of those who saw their family doctor about suspicious symptoms were referred to a hospital after only one or two consultations.

However, the study found that women, young people, non-white patients and patients with less common cancers were more likely to see their family doctor three or more times before they were referred to a hospital.

The researchers identified large differences in the promptness of family doctors in England to diagnose different types of cancer. Patients with symptoms of multiple myeloma, lung and pancreatic cancer required many more consultations with their family doctor before they were referred to a hospital, compared to patients with more common cancers such as breast, melanoma and testicular.

For example, almost 51 percent of patients with the blood cancer multiple myeloma required multiple visits to their family doctor before referral, compared with less than 8 percent of breast cancer patients.

Differences in the nature and characteristics of symptoms may explain why certain cancers are more difficult to diagnose, the researchers said. For example, multiple myeloma is especially difficult to diagnose because it mimics other conditions, while a breast lump may readily suggest cancer, the authors said.

They also said that doctors may be less likely to consider cancer in younger patients and may have communication difficulties with patients from different ethnic groups, which may explain why cancer diagnoses can take longer in these patients.

The study appears online Feb. 24 in The Lancet Oncology.

"These findings highlight limitations in current scientific knowledge," lead author Georgios Lyratzopoulos, of Cambridge University, said in a journal news release. "Medical research in recent decades has prioritized improving cancer treatments, but knowledge about the 'symptom signature' of common cancers and practical solutions on how best to diagnose them is still emerging."

Martin Guilliford, of King's College London, wrote in an accompanying editorial that the findings raise several questions that should be tested in future research.

He said some of those questions are: "Do modes of cancer presentation vary systematically between different groups of patients? Are (family doctors) more reluctant to refer young or non-white patients for investigation of possible cancer? Are participants in these groups less willing to accept a referral to investigate possible cancer?"

More information

The American Academy of Family Physicians has more about cancer diagnosis and tests.

-- Robert Preidt

SOURCE: The Lancet Oncology, news release, Feb. 21, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Supports CT-Based Virtual Colonoscopy to Spot Colon Cancer
2. Breaking down cancers defense for future vaccines
3. Scripps Florida scientists uncover inflammatory circuit that triggers breast cancer
4. Colonoscopy prevents deaths from colon cancer
5. Obesity may modify the association between alcohol consumption and the risk of colorectal cancer
6. Colon Cancer Alliance and American College of Radiology demand Medicare cover virtual colonoscopy
7. Stronger intestinal barrier may prevent cancer in the rest of the body, new study suggests
8. FDA Moves to Head Off Shortages of 2 Cancer Drugs
9. Mapping of protein inhibitors facilitates development of tailor-made anticancer agents
10. New blood test for early cancer detection developed by Ben-Gurion University researchers
11. Telomere failure, telomerase activation drive prostate cancer progression
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Why Cancer Symptoms May Elude M.D.
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... Philadelphia and Theater of Witness , was awarded a $300,000 grant ... humanities program which fosters empathy, comfort with ambiguity and the recognition of one’s ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed a ... ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand ... Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is ...
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has launched ... of acceptance to a residency in a United States hospital. Being accepted into ... U.S. , According to data released by the ECFMG®, every year, 50 percent ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... West Dermatology ... Tuantu Doan Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s ... years of experience in dermatology, skin cancer , and more. She graduated from ...
(Date:7/21/2017)... ... 21, 2017 , ... How physicians and athletic trainers assess ... researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s ... the patterns of change in concussion symptom presentation, diagnostic tools used and length ...
Breaking Medicine News(10 mins):
(Date:7/1/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced ... broadcast live over the Internet on Thursday, July 27, 2017, ... quarterly results will be made available at 7:30 a.m. Eastern ... live audio webcast can be accessed via Zimmer Biomet,s Investor ... for replay following the conference call. ...
(Date:6/30/2017)... June 29, 2017  Axium Pharmaceuticals Inc. is a pharmaceutical company ... formulations and alternative dosage forms of existing biologically active molecule. ... ... our waterless self-nano emulsifying formula, which is designed to prevent ... believe the spray will provide fast onset of action and ...
(Date:6/20/2017)... and LAGUNA HILLS, Calif. , ... of new data that validate the use of MMprofiler ... patients with multiple myeloma (MM). In a poster presentation ... Hematology Association (EHA) in Madrid, Spain ... MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: